206 related articles for article (PubMed ID: 15785751)
21. Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy.
Magnusson C; Baron JA; Correia N; Bergström R; Adami HO; Persson I
Int J Cancer; 1999 May; 81(3):339-44. PubMed ID: 10209946
[TBL] [Abstract][Full Text] [Related]
22. Risk of breast cancer in post-menopausal women using hormone replacement therapy.
Ratanawichitrasin A; Reansuwan W; Ratanawichitrasin S; Bhodhisuwan K; Kongpatanakul S
J Med Assoc Thai; 2002 May; 85(5):583-9. PubMed ID: 12188389
[TBL] [Abstract][Full Text] [Related]
23. Hormone Replacement Therapy, Breast Cancer Risk Factors, and Breast Cancer Risk: A Nationwide Population-Based Cohort.
Yoo TK; Han KD; Kim D; Ahn J; Park WC; Chae BJ
Cancer Epidemiol Biomarkers Prev; 2020 Jul; 29(7):1341-1347. PubMed ID: 32299849
[TBL] [Abstract][Full Text] [Related]
24. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
25. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
[TBL] [Abstract][Full Text] [Related]
26. HRT and breast cancer: impact on population risk and incidence.
Coombs NJ; Taylor R; Wilcken N; Boyages J
Eur J Cancer; 2005 Aug; 41(12):1775-81. PubMed ID: 16087330
[TBL] [Abstract][Full Text] [Related]
27. [Effects of hormone replacement therapy for menopause on prognostic factors of breast cancer].
Bonnier P; Sakr R; Bessenay F; Lejeune C; Charpin C; Martin PM; Piana L
Gynecol Obstet Fertil; 2000 Oct; 28(10):745-53. PubMed ID: 11244637
[TBL] [Abstract][Full Text] [Related]
28. A population-based cohort study of HRT use and breast cancer in Korea.
Park SB; Shin HR; Lee SY
Asia Pac J Public Health; 2012 Mar; 24(2):415-22. PubMed ID: 21266394
[TBL] [Abstract][Full Text] [Related]
29. Exogenous steroids for menopausal symptoms and breast/endometrial cancer risk.
Mourits MJ; DE Bock GH
Int J Gynecol Cancer; 2006; 16 Suppl 2():494-6. PubMed ID: 17010054
[TBL] [Abstract][Full Text] [Related]
30. Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers.
Kotsopoulos J; Gronwald J; Karlan BY; Huzarski T; Tung N; Moller P; Armel S; Lynch HT; Senter L; Eisen A; Singer CF; Foulkes WD; Jacobson MR; Sun P; Lubinski J; Narod SA;
JAMA Oncol; 2018 Aug; 4(8):1059-1065. PubMed ID: 29710224
[TBL] [Abstract][Full Text] [Related]
31. Hormone replacement therapy and cancer risks in perimenopausal women: A retrospective cohort study using a Japanese claims database.
Inayama Y; Mizuno K; Yamaguchi K; Hamanishi J; Takeuchi M; Egawa M; Mandai M; Kawakami K
J Obstet Gynaecol Res; 2023 Jul; 49(7):1805-1814. PubMed ID: 37029559
[TBL] [Abstract][Full Text] [Related]
32. Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation.
Corrao G; Zambon A; Conti V; Nicotra F; La Vecchia C; Fornari C; Cesana G; Contiero P; Tagliabue G; Nappi RE; Merlino L
Ann Oncol; 2008 Jan; 19(1):150-5. PubMed ID: 17785762
[TBL] [Abstract][Full Text] [Related]
33. Menopausal hormone therapy and the risk of breast cancer by histological type and race: a meta-analysis of randomized controlled trials and cohort studies.
Kim S; Ko Y; Lee HJ; Lim JE
Breast Cancer Res Treat; 2018 Aug; 170(3):667-675. PubMed ID: 29713854
[TBL] [Abstract][Full Text] [Related]
34. Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study.
Azam S; Lange T; Huynh S; Aro AR; von Euler-Chelpin M; Vejborg I; Tjønneland A; Lynge E; Andersen ZJ
Cancer Causes Control; 2018 Jun; 29(6):495-505. PubMed ID: 29671181
[TBL] [Abstract][Full Text] [Related]
35. The choice of progestogen for HRT in menopausal women: breast cancer risk is a major issue.
Ruan X; Mueck AO
Horm Mol Biol Clin Investig; 2018 Aug; 37(1):. PubMed ID: 30120909
[TBL] [Abstract][Full Text] [Related]
36. Hormone replacement therapy and breast cancer in former users of oral contraceptives--The Norwegian Women and Cancer study.
Lund E; Bakken K; Dumeaux V; Andersen V; Kumle M
Int J Cancer; 2007 Aug; 121(3):645-8. PubMed ID: 17372914
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer and hormone-replacement therapy in the Million Women Study.
Beral V;
Lancet; 2003 Aug; 362(9382):419-27. PubMed ID: 12927427
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer and hormonal replacement therapy.
Vassilopoulou-Sellin R
Ann N Y Acad Sci; 2003 Nov; 997():341-50. PubMed ID: 14644841
[TBL] [Abstract][Full Text] [Related]
39. Hormone replacement therapy and breast cancer risk in California.
Coombs NJ; Taylor R; Wilcken N; Fiorica J; Boyages J
Breast J; 2005; 11(6):410-5. PubMed ID: 16297085
[TBL] [Abstract][Full Text] [Related]
40. Associations of body fat mass and fat-free mass with breast cancer incidence in postmenopausal women: A Danish prospective cohort study.
Gram MA; Olsen A; Andersen ZJ; Tjønneland A; Mellemkjær L
Ann Epidemiol; 2023 Apr; 80():30-36. PubMed ID: 36750141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
